Company / Depreciation & Amortization
Coherus Oncology, Inc. Depreciation & Amortization History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$3.3M
FY2019
5-year range
$404.0K / $3.4M
FY2015-FY2019
Trend
+0.7%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2019 with a 5-year CAGR of +71.3%.
Improved from $3M to $3M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +69.1%
- 5-Year CAGR
- +71.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +71.3%, indicating consistent growth.
- In FY2019, depreciation & amortization increased 0.7% year-over-year.
- Peak depreciation & amortization was recorded in FY2017.
- Lowest depreciation & amortization in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $3.3M | +0.7% |
| FY2018 | $3.2M | -4.8% |
| FY2017 | $3.4M | +404.2% |
| FY2016 | $674.0K | +66.8% |
| FY2015 | $404.0K | +82.8% |
| FY2014 | $221.0K | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026